Clinical Trial Update: Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Faslodex with or without concomitant Arimidex versus Exemestane after progression on non-steroidal aromatase inhibitors has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Exemestane (Exemestane)
• Faslodex (fulvestrant)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-06-04